BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin H, Wu YS, Li Z, Jiang Y. Prognostic value of retrieved lymph node counts in patients with node-negative perihilar cholangiocarcinomas. ANZ J Surg 2018;88:E829-34. [PMID: 30207026 DOI: 10.1111/ans.14775] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Chen S, He S, Cigerci İH. Bioinformatics Analysis of Inflammation Gene Signature in Indicating Cholangiocarcinoma Prognosis. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/9975838] [Reference Citation Analysis]
2 Park HJ, Han DH, Choi GH, Choi JS. Surgical outcomes of perihilar cholangiocarcinoma based on the learning curve of a single surgeon at a tertiary academic hospital: A retrospective study. Ann Hepatobiliary Pancreat Surg 2021;25:54-61. [PMID: 33649255 DOI: 10.14701/ahbps.2021.25.1.54] [Reference Citation Analysis]
3 Cipriani F, Ratti F, Fiorentini G, Reineke R, Aldrighetti L. Systematic review of perioperative and oncologic outcomes of minimally-invasive surgery for hilar cholangiocarcinoma. Updates Surg 2021;73:359-77. [PMID: 33615423 DOI: 10.1007/s13304-021-01006-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
4 Hau HM, Meyer F, Jahn N, Rademacher S, Sucher R, Seehofer D. Prognostic Relevance of the Eighth Edition of TNM Classification for Resected Perihilar Cholangiocarcinoma. J Clin Med 2020;9:E3152. [PMID: 33003424 DOI: 10.3390/jcm9103152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]